7 is the total number of securities Qiming U.S. Ventures Management, LLC has owned. The longest Qiming U.S. Ventures Management, LLC has owned a single stock is 8 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
ICOSAVAX INC | 8 | 8 | 16.11% | 29.81% | 36.96% | Q4 2021 | Q3 2023 | 8 | |
VENTYX BIOSCIENCES INC | 8 | 8 | 8.32% | 24.15% | 37.85% | Q4 2021 | Q3 2023 | 8 | |
TALS | TALARIS THERAPEUTICS INC | 8 | 8 | 3.96% | 13.53% | 27.11% | Q4 2021 | Q3 2023 | 8 |
JASPER THERAPEUTICS INC | 8 | 8 | 3.74% | 13.20% | 21.14% | Q4 2021 | Q3 2023 | 8 | |
KZR | KEZAR LIFE SCIENCES INC | 8 | 8 | 1.31% | 6.69% | 12.94% | Q4 2021 | Q3 2023 | 8 |
ELEV | ELEVATION ONCOLOGY INC | 8 | 8 | 2.08% | 4.37% | 6.57% | Q4 2021 | Q3 2023 | 8 |
HILLEVAX INC | 6 | 6 | 8.48% | 11.00% | 13.88% | Q2 2022 | Q3 2023 | 6 | |
Download |
The securities at the top of the list , including ICOSAVAX INC, VENTYX BIOSCIENCES INC, and TALARIS THERAPEUTICS INC, are the highest-conviction holdings of Qiming U.S. Ventures Management, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Qiming U.S. Ventures Management, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Qiming U.S. Ventures Management, LLC owns currently or has owned in the past.